Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screening.

The role of biomarkers in risk-based early detection of lung cancer may enable screening to become cost effective and widely accessible. EarlyCDT-Lung is an example of such a blood-based autoantibody biomarker which may improve accessibility to Low dose Computed Tomography (LDCT) screening for those...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Francis Michael Sullivan, Frances S Mair, William Anderson, Cindy Chew, Alistair Dorward, John Haughney, Fiona Hogarth, Denise Kendrick, Roberta Littleford, Alex McConnachie, Colin McCowan, Nicola McMeekin, Manish Patel, Petra Rauchhaus, Fergus Daly, Lewis Ritchie, John Robertson, Joseph Sarvesvaran, Herbert Sewell, Thomas Taylor, Shaun Treweek, Kavita Vedhara, Stuart Schembri
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2025-01-01
coleção:	PLoS ONE
Acesso em linha:	https://doi.org/10.1371/journal.pone.0306163
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!